Clinical Trials Browser

Phase 1 × Breast Neoplasms × decitabine and cedazuridine drug combination × Clear all

NCT04134884 2024-03-22

Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast Cancer

Phase 1 Completed

Breast Neoplasms, Triple Negative Breast Neoplasms